Anzeige
Mehr »
Samstag, 06.12.2025 - Börsentäglich über 12.000 News
Das Timing könnte nicht besser sein - Durchbruchsjahr 2026 für Myriad
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Cantech Letter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
27.11.Sabio Holdings is still a buy, this analyst says
26.11.Meet the man behind Michael Burry's big AI short
26.11.Shorters won't take down Capricor Therapeutics, this analyst says
26.11.Is Semtech a buy right now?
25.11.Here's what RBC thinks about Air Canada's stock right now
25.11.Competition Bureau investigation into WELL Health is not a concern, Stifel says
25.11.This Canadian biotech stock is looking to treat spinal cord injuries
25.11.No, Adobe won't be killed by AI, this investor says
25.11.This Canadian biotech stock is tackling pancreatic Cancer
24.11.Upwork is a buy, this analyst says
24.11.This analyst loves Extendicare
24.11.Should you sell your Real Matters stock?
24.11.Propel Holdings. Buy, Sell or Hold?
24.11.Will AI reshape OpenText?
24.11.Altus Group. Buy, Sell or Hold?
23.11.What happened to Motorola stock?
23.11.Should you sell your AI stocks right now?
21.11.This tech stock is a great play on mortgage rates, analyst says
21.11.Walmart is dramatically separating itself from brick and mortar, analyst says
20.11.Decibel Cannabis. Buy, Sell or Hold?
20.11.Lululemn faces an uphill battle, this analyst says
20.11.Xtract One Technologies CFO Karen Hersh talks to Cantech Letter
20.11.Rocket Doctor CEO, Dr. Essam Hamza, talks to Cantech Letter
19.11.Analyst: Here's why Target is failing
19.11.This analyst just upgraded Telus